| 2021 |
Briot K, Schott A-M, Sanchez J-P, Chauny J-V, Samama P, Désaméricq G. High persistence over two years with denosumab among postmenopausal women with osteoporosis in France: a prospective cohort study. Bone. May 2021;146:115890. |
0 |
0 |
| 2022 |
Cortet B, Schott A-M, Désaméricq G, Chauny J-V, Samama P, Emery C, Fagnani F. Trends in postmenopausal osteoporosis treatment in France during the period 2007–2016: a nationwide claims database analysis. Bone. January 2022;154:116255. |
0 |
0 |
| 1998 |
Schott AM, Cormier C, Hans D, Favier F, Hausherr E, Dargent-Molina P, Delmas PD, Ribot C, Sebert JL, Breart G, Meunier PJ; EPIDOS Group. How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS prospective study. Osteoporos Int. May 1998;8(3):247-254. |
20 |
17 |
| 2007 |
Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Glüer C, Goltzman D, Hans D, Krieg M-A, La Croix A, McCloskey E, Mellstrom D, Melton LJ, Pols H, Reeve J, Sanders K, Schott A-M, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. August 2007;18(8):1033-1046. |
66 |
41 |
| 2020 |
Martin J, Viprey M, Castagne B, Merle B, Giroudon C, Chapurlat R, Schott A-M. Interventions to improve osteoporosis care: a systematic review and meta-analysis. Osteoporos Int. March 2020;31(3):429-446. |
0 |
0 |